INSP - Inspire Medical Systems, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.61B
Enterprise Value 31.48B
Trailing P/E N/A
Forward P/E 1-42.74
PEG Ratio (5 yr expected) 1-2.26
Price/Sales (ttm)25.27
Price/Book (mrq)10.58
Enterprise Value/Revenue 323.17
Enterprise Value/EBITDA 6-56.75

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 331.51%
S&P500 52-Week Change 31.11%
52 Week High 369.71
52 Week Low 335.43
50-Day Moving Average 366.20
200-Day Moving Average 357.69

Share Statistics

Avg Vol (3 month) 3290.54k
Avg Vol (10 day) 3212.85k
Shares Outstanding 523.81M
Float 17.19M
% Held by Insiders 18.50%
% Held by Institutions 185.65%
Shares Short (Jul 31, 2019) 4676.89k
Short Ratio (Jul 31, 2019) 42.56
Short % of Float (Jul 31, 2019) 43.81%
Short % of Shares Outstanding (Jul 31, 2019) 42.83%
Shares Short (prior month Jun 28, 2019) 4772.25k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin -39.73%
Operating Margin (ttm)-41.47%

Management Effectiveness

Return on Assets (ttm)-10.37%
Return on Equity (ttm)-19.91%

Income Statement

Revenue (ttm)63.9M
Revenue Per Share (ttm)2.82
Quarterly Revenue Growth (yoy)64.90%
Gross Profit (ttm)40.54M
EBITDA -26.09M
Net Income Avi to Common (ttm)-25.39M
Diluted EPS (ttm)-1.12
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)158.62M
Total Cash Per Share (mrq)6.63
Total Debt (mrq)24.41M
Total Debt/Equity (mrq)16.01
Current Ratio (mrq)20.46
Book Value Per Share (mrq)6.38

Cash Flow Statement

Operating Cash Flow (ttm)-29.97M
Levered Free Cash Flow (ttm)-22.13M